Content
07/23/2025
Boston, MA USA
Dash Bio
completed $11 million Series A Round funding. Investors include
The Aligned Fund (lead), FreeStyle Capital, Cybernetix Ventures, Swift Ventures, LifeX Ventures, Drive Capital.
About
Dash Bio accelerates clinical development by delivering high-quality, technology-driven bioanalysis at unprecedented speed. Its fully automated, GLP-compliant lab platform combines robotics, AI, and integrated software to deliver faster results and better data — helping biopharma teams get therapies to patients faster.
Startup
Sector:
Biotech
Life Science
Software
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
